Literature DB >> 8521589

Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.

M R Costanzo1, S Augustine, R Bourge, M Bristow, J B O'Connell, D Driscoll, E Rose.   

Abstract

Improved outcome of heart failure in response to medical therapy, coupled with a critical shortage of donor organs, makes it imperative to restrict heart transplantation to patients who are most disabled by heart failure and who are likely to derive the maximum benefit from transplantation. Hemodynamic and functional indexes of prognosis are helpful in identifying these patients. Stratification of ambulatory heart failure patients by objective criteria, such as peak exercise oxygen consumption, has improved ability to select appropriate adult patients for heart transplantation. Such patients will have a poor prognosis despite optimal medical therapy. When determining the impact of individual comorbid conditions on a patient's candidacy for heart transplantation, the detrimental effects of each condition on posttransplantation outcome should be weighed. Evaluation of patients with severe heart failure should be done by a multidisciplinary team that is expert in management of heart failure, performance of cardiac surgery in patients with low left ventricular ejection fraction, and transplantation. Potential heart transplant candidates should be reevaluated on a regular basis to assess continued need for transplantation. Long-term management of heart failure should include continuity of care by an experienced physician, optimal dosing in conventional therapy, and periodic reevaluation of left ventricular function and exercise capacity. The outcome of high-risk conventional cardiovascular surgery should be weighed against that of transplantation in patients with ischemic and valvular heart disease. Establishment of regional specialized heart failure centers may improve access to optimal medical therapy and new promising medical and surgical treatments for these patients as well as stimulate investigative efforts to accelerate progress in this critical area.

Entities:  

Mesh:

Year:  1995        PMID: 8521589     DOI: 10.1161/01.cir.92.12.3593

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

Review 1.  Exercise testing in the assessment of chronic congestive heart failure.

Authors:  John G Lainchbury; A Mark Richards
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

2.  Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: relation to timing and extent of functional recovery.

Authors:  D Czitrom; D Karila-Cohen; E Brochet; J M Juliard; M Faraggi; M C Aumont; P Assayag; P G Steg
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

Review 3.  Acute cardiovascular response to exercise and its implications for exercise testing.

Authors:  Sachin M Navare; Paul D Thompson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

Review 4.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

5.  Titin isoform switching is a major cardiac adaptive response in hibernating grizzly bears.

Authors:  O Lynne Nelson; Charles T Robbins; Yiming Wu; Henk Granzier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-23       Impact factor: 4.733

6.  Long term results of heart transplantation in patients with amyloid heart disease.

Authors:  S W Dubrey; M M Burke; A Khaghani; P N Hawkins; M H Yacoub; N R Banner
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 7.  Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.

Authors:  Christopher W Jensen; Andrew B Goldstone; Y Joseph Woo
Journal:  Curr Heart Fail Rep       Date:  2016-06

Review 8.  The role of exercise testing in the evaluation and management of heart failure.

Authors:  D J Wright; L B Tan
Journal:  Postgrad Med J       Date:  1999-08       Impact factor: 2.401

Review 9.  Cardiopulmonary exercise testing and its application.

Authors:  Khaled Albouaini; Mohaned Egred; Albert Alahmar; David Justin Wright
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

10.  The role of exercise on L-arginine nitric oxide pathway in chronic heart failure.

Authors:  A C Mendes-Ribeiro; G E Mann; L R de Meirelles; M B Moss; C Matsuura; T M C Brunini
Journal:  Open Biochem J       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.